XEROSTOMIA THERAPEUTICS MARKET ANALYSIS
Global Xerostomia Therapeutics Market: Competitive landscape
The major players operating in the xerostomia therapeutics market include Eisai Inc., Hikma Pharmaceuticals, Synedgen, 3M, Lupin Pharmaceuticals, Inc., Apotex Inc., Church & Dwight Co. Inc., Parnell Pharmaceuticals, Colgate-Palmolive Co., EUSA Pharma, Cumberland Pharmaceuticals Inc., OraHealth Inc., Daiichi Sankyo Co. Ltd., Forward Science, Eisai Co. Ltd., GlaxoSmithKline Plc, Pharmascience Inc., Mission Pharmacal Company, Quest Products Inc., Saliwell Ltd., Sun Pharmaceutical Industries Ltd., and Dentaid.
Market players are focused on adoption of inorganic growth strategies such as acquisitions and collaborations, in order to enhance their product portfolio in the potential market. For instance, in July 2015, Hikma Pharmaceuticals acquired Roxane Laboratories, which is a part of West-Ward Pharmaceuticals Corp, for product profile enhancement in oral care segment. Moreover, in May 2018, Moisyn products developed by the oral care division of Synedgen have been approved for marketing by the U.S. Food and Drug Administration (FDA) to treat xerostomia.
Xerostomia Therapeutics Market Report Snapshots
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients